RxDoctor Payments Data

Tiffany Woody

Family · Burnsville, NCNPI 1437507498

Payments from drug & device makers

$1,298in general payments, 2019–2025

Across 17 payments — averaging $76.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ortho Development Corporation$1K
  • AbbVie$73
  • Novartis$50
  • Gilead$34
  • Novo Nordisk$30
  • Takeda Pharmaceuticals U.S.A., Inc.$27
  • plus $43 from 3 others

What the payments were for

  • Travel & lodging$1,04080%
  • Food & beverage$25820%

General payments by program year

21
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,298 in reported general payments places this provider in the 75th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$631
Medicare patients
42
Services billed
96

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide33$36,590
OzempicSemaglutide25$30,292
JardianceEmpagliflozin26$27,813
XareltoRivaroxaban24$22,725
EliquisApixaban24$22,437
TrulicityDulaglutide17$15,620
RybelsusSemaglutide12$14,779
SymbicortBudesonide/Formoterol Fumarate21$12,218
Bupropion XlBupropion Hcl63$5,746
Advair DiskusFluticasone Propion/Salmeterol14$3,752
Fluticasone-SalmeterolFluticasone Propion/Salmeterol17$3,371
Duloxetine Hcl124$2,132
Gabapentin94$2,033
Omeprazole182$1,962
Venlafaxine Hcl ErVenlafaxine Hcl51$1,905

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$30$45,07137 claims
AbbVieLinzess, Synthroid$73$38,43759 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,522 family providers in North Carolina.

Other family in Burnsville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →